{"id":40169,"date":"2024-03-04T07:39:53","date_gmt":"2024-03-04T12:39:53","guid":{"rendered":"https:\/\/osteomag.ca\/?p=40169"},"modified":"2025-01-22T05:34:49","modified_gmt":"2025-01-22T10:34:49","slug":"raynauds-disease-understanding-abnormal-vascular-response","status":"publish","type":"post","link":"https:\/\/osteomag.ca\/en\/raynauds-disease-understanding-abnormal-vascular-response\/","title":{"rendered":"Raynaud&#8217;s Disease: an Abnormal Vascular Response"},"content":{"rendered":"\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #000000;color:#000000\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #000000;color:#000000\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/osteomag.ca\/en\/raynauds-disease-understanding-abnormal-vascular-response\/#Introduction\" >Introduction<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/osteomag.ca\/en\/raynauds-disease-understanding-abnormal-vascular-response\/#Causes\" >Causes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/osteomag.ca\/en\/raynauds-disease-understanding-abnormal-vascular-response\/#Symptoms\" >Symptoms<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/osteomag.ca\/en\/raynauds-disease-understanding-abnormal-vascular-response\/#Pathophysiology\" >Pathophysiology<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/osteomag.ca\/en\/raynauds-disease-understanding-abnormal-vascular-response\/#Diagnosis_and_Treatment\" >Diagnosis and Treatment<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/osteomag.ca\/en\/raynauds-disease-understanding-abnormal-vascular-response\/#Diagnostic\" >Diagnostic<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/osteomag.ca\/en\/raynauds-disease-understanding-abnormal-vascular-response\/#Treatment\" >Treatment<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/osteomag.ca\/en\/raynauds-disease-understanding-abnormal-vascular-response\/#Prevention\" >Prevention<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/osteomag.ca\/en\/raynauds-disease-understanding-abnormal-vascular-response\/#Conclusion\" >Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/osteomag.ca\/en\/raynauds-disease-understanding-abnormal-vascular-response\/#References\" >References<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading has-white-color has-text-color has-background has-link-color wp-elements-7d15a2b64d31353c30b386f998a19865\" style=\"background-color:#2a4a3b\"><span class=\"ez-toc-section\" id=\"Introduction\"><\/span><strong>Introduction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Raynaud&#8217;s disease is a vascular condition characterized by sudden constriction of the small arteries that supply blood to the extremities of the body, primarily the fingers and toes.&nbsp;This phenomenon causes a temporary decrease in blood flow, leading to paleness or cyanosis of the skin, followed by redness and sometimes swelling when blood flow is restored.&nbsp;Episodes of Raynaud&#8217;s disease may be triggered by cold, emotional stress, or other factors that cause an abnormal vascular response.<\/p>\n\n\n\n<p>This disease, often classified as primary or secondary, can have significant implications on the quality of life of individuals who suffer from it.&nbsp;In its primary form, Raynaud&#8217;s disease occurs independently of other medical conditions, while the secondary form is often associated with autoimmune diseases such as lupus or scleroderma.&nbsp;Women are more commonly affected than men, and the first symptoms generally appear between adolescence and the thirties.<\/p>\n\n\n\n<p>Episodes of Raynaud&#8217;s disease can be uncomfortable or even painful, and management of this condition aims to reduce the frequency and severity of attacks.&nbsp;Strategies include avoiding known triggers such as extreme cold, wearing warm clothing, and using relaxation techniques to manage stress.&nbsp;In some cases, vasodilator medications may be prescribed to help dilate blood vessels and improve blood flow.<\/p>\n\n\n\n<p>In addition to physical symptoms, Raynaud&#8217;s disease can have a psychological impact due to the unpredictable nature of the attacks and their impact on daily activities.&nbsp;Psychological support and education on disease management play a crucial role in supporting those affected.<\/p>\n\n\n\n<p>Although Raynaud&#8217;s disease is not generally considered life-threatening, it requires medical attention to assess the severity of symptoms and rule out other underlying conditions.&nbsp;Treatment approaches are personalized based on the severity of the disease and its implications on the patient&#8217;s daily life.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-white-color has-text-color has-background has-link-color wp-elements-9025191fe16be2a9b76ae7f1aa05f02b\" style=\"background-color:#2a4a3b\"><span class=\"ez-toc-section\" id=\"Causes\"><\/span><strong>Causes<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Abnormal Vascular Reactivity:<\/strong>&nbsp;In Raynaud&#8217;s syndrome, the small arteries in the fingers and toes overreact to certain triggers, contracting abnormally in response to cold or stress.&nbsp;This excessive constriction reduces blood flow to these areas, leading to the characteristic symptoms.<\/li>\n\n\n\n<li><strong>Genetic Factors:<\/strong>&nbsp;There is a genetic component to the development of Raynaud&#8217;s syndrome.&nbsp;A family history of the disease increases the risk of developing it.&nbsp;Certain genes associated with the regulation of blood circulation may play a role in genetic predisposition.<\/li>\n\n\n\n<li><strong>Endothelial Dysfunction:<\/strong>&nbsp;The endothelium, the inner layer of blood vessels, plays a crucial role in regulating vascular tone.&nbsp;Endothelial dysfunction may contribute to the excessive constriction of blood vessels seen in Raynaud syndrome.<\/li>\n\n\n\n<li><strong>Autoimmune Disorders:<\/strong>&nbsp;Raynaud&#8217;s syndrome is sometimes associated with autoimmune diseases such as systemic lupus erythematosus and scleroderma, where the immune system attacks the body&#8217;s tissues, including blood vessels.<\/li>\n\n\n\n<li><strong>Hormonal Imbalances:<\/strong>&nbsp;Hormonal fluctuations, particularly in women, can influence vascular reactivity.&nbsp;Female hormones, such as estrogen, can impact blood flow.<\/li>\n\n\n\n<li><strong>Exposure to Industrial Substances:<\/strong>&nbsp;Certain work environments may expose individuals to excessive vibrations, such as those produced by the use of certain power tools.&nbsp;This prolonged exposure may contribute to the development of Raynaud&#8217;s syndrome.<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading has-white-color has-text-color has-background has-link-color wp-elements-15801028e2c2fea60f837654c5e7dd96\" style=\"background-color:#2a4a3b\"><span class=\"ez-toc-section\" id=\"Symptoms\"><\/span><strong>Symptoms<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter\"><img decoding=\"async\" width=\"400\" height=\"269\" src=\"https:\/\/osteomag.ca\/wp-content\/uploads\/2024\/02\/rh053.webp\" alt=\"\" class=\"wp-image-38973\" srcset=\"https:\/\/osteomag.ca\/wp-content\/uploads\/2024\/02\/rh053.webp 400w, https:\/\/osteomag.ca\/wp-content\/uploads\/2024\/02\/rh053-80x54.webp 80w, https:\/\/osteomag.ca\/wp-content\/uploads\/2024\/02\/rh053-150x101.webp 150w, https:\/\/osteomag.ca\/wp-content\/uploads\/2024\/02\/rh053-300x202.webp 300w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/figure>\n<\/div>\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Skin Color Changes:<\/strong>&nbsp;During a Raynaud&#8217;s attack, the fingers and toes may first turn white (ischemia) due to excessive constriction of small arteries, limiting blood flow to these areas.<\/li>\n\n\n\n<li><strong>Cyanosis:<\/strong>&nbsp;Then, the skin color may change to blue or purple (cyanosis) due to decreased blood oxygen levels and reduced blood flow.&nbsp;Cyanosis is often most visible in the affected extremities.<\/li>\n\n\n\n<li><strong>Hyperemia:<\/strong>&nbsp;When blood flow returns, fingers and toes may turn bright red (hyperemia), accompanied by a tingling or burning sensation.&nbsp;This stage may be associated with some pain or a feeling of numbness.<\/li>\n\n\n\n<li><strong>Numbness or Tingling:<\/strong>&nbsp;People with Raynaud&#8217;s may experience numbness, tingling, or a burning sensation in their fingers, toes, or other affected body parts during and after an attack.<\/li>\n\n\n\n<li><strong>Sensitivity to Cold:<\/strong>&nbsp;Hypersensitivity to cold is frequently observed in people with Raynaud&#8217;s.&nbsp;Even mild exposure to cold can trigger an attack.<\/li>\n\n\n\n<li><strong>Variable Duration of Seizures:<\/strong>&nbsp;Raynaud&#8217;s seizures can vary in duration, from a few minutes to several hours.&nbsp;The frequency of seizures can also vary, with some people having them rarely, while others may experience them frequently.<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading has-white-color has-text-color has-background has-link-color wp-elements-86fee34833f89452b75c22dccd18af21\" style=\"background-color:#2a4a3b\"><span class=\"ez-toc-section\" id=\"Pathophysiology\"><\/span><strong>Pathophysiology<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><br>The pathophysiology of Raynaud&#8217;s syndrome involves abnormalities in the regulation of peripheral blood circulation, particularly in the small arteries of the fingers and toes.&nbsp;This vascular dysregulation leads to episodes of excessive constriction of blood vessels, usually in response to cold or emotional stress.&nbsp;Understanding the underlying mechanisms of this condition helps explain the characteristic symptoms observed in individuals with Raynaud syndrome.<\/p>\n\n\n\n<p>Here are the main components of the pathophysiology of Raynaud syndrome:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Exaggerated Vascular Response:<\/strong>&nbsp;When people with Raynaud&#8217;s are exposed to cold or experience emotional stress, their blood vessels react in an exaggerated manner.&nbsp;Instead of maintaining normal vascular diameter, small arteries constrict excessively, limiting blood flow to the extremities.<\/li>\n\n\n\n<li><strong>Constriction of Arteries:<\/strong>&nbsp;Excessive constriction of arteries, also called vasoconstriction, reduces the amount of blood that can reach the fingers, toes and other affected parts of the body.&nbsp;This leads to a decreased supply of oxygen to the tissues, which can cause color and temperature changes in the skin.<\/li>\n\n\n\n<li><strong>Temporary Ischemia:<\/strong>&nbsp;When the constriction of the arteries is severe, it can lead to temporary ischemia, i.e. a reduction in blood flow to the affected region.&nbsp;This manifests itself as whitening of the skin and a feeling of cold.<\/li>\n\n\n\n<li><strong>Reperfusion and Hyperemia:<\/strong>&nbsp;When vasoconstriction decreases, often in response to warming or reduced stress, blood flow can increase rapidly, leading to hyperemia.&nbsp;This phase is characterized by reddening of the skin and may be accompanied by tingling or burning sensations.<\/li>\n\n\n\n<li><strong>Endothelial Dysfunction:<\/strong>&nbsp;Studies suggest that endothelial dysfunction, which affects the inner layer of blood vessels called the endothelium, plays a role in the pathophysiology of Raynaud&#8217;s syndrome.&nbsp;The endothelium plays a crucial role in regulating vascular tone, and any alteration in this function may contribute to the abnormal vascular response seen in Raynaud syndrome.<\/li>\n\n\n\n<li><strong>Immune and Autoimmune Reactions:<\/strong>&nbsp;In some cases, Raynaud&#8217;s syndrome is associated with autoimmune diseases, such as systemic lupus erythematosus and scleroderma.&nbsp;In these situations, abnormal immune responses may contribute to the vascular dysregulation characteristic of Raynaud&#8217;s syndrome.<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading has-white-color has-text-color has-background has-link-color wp-elements-329b6773561352e2a707019f8de2a67b\" style=\"background-color:#2a4a3b\"><span class=\"ez-toc-section\" id=\"Diagnosis_and_Treatment\"><\/span><strong>Diagnosis and Treatment<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading has-vivid-cyan-blue-color has-text-color has-link-color wp-elements-02418074cb5a9490ce1a61cc7a0cbbdf\"><span class=\"ez-toc-section\" id=\"Diagnostic\"><\/span><strong><br>Diagnostic<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>The diagnosis of Raynaud&#8217;s syndrome is based on a thorough assessment of symptoms, the patient&#8217;s medical history, and clinical examination findings.&nbsp;Diagnostic steps include:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Medical Interview:<\/strong>&nbsp;The doctor collects information about symptoms, frequency, potential triggers and other medical aspects.<\/li>\n\n\n\n<li><strong>Physical Examination:<\/strong>&nbsp;A physical examination is performed to evaluate changes in color, temperature, and sensation in the fingers, toes, and other affected body parts.<\/li>\n\n\n\n<li><strong>Laboratory Tests:<\/strong>&nbsp;Blood tests may be done to rule out other medical conditions that might present with similar symptoms.<\/li>\n\n\n\n<li><strong>Imaging Tests:<\/strong>&nbsp;Thermography, which measures skin temperature, can be used to assess blood circulation in affected areas.<\/li>\n\n\n\n<li><strong>Provocation Tests:<\/strong>&nbsp;Provocation tests, such as the cold test, can be performed in the clinic to trigger a vascular response and observe blood vessel reactions.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading has-vivid-cyan-blue-color has-text-color has-link-color wp-elements-9762c6d63fb034e2221a6a00933fe70f\"><span class=\"ez-toc-section\" id=\"Treatment\"><\/span><strong>Treatment<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Treatment of Raynaud&#8217;s syndrome aims to alleviate symptoms, prevent complications and improve quality of life.&nbsp;Treatment approaches may include:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Avoidance of Triggers:<\/strong>&nbsp;People with Raynaud&#8217;s are often advised to avoid triggers such as extreme cold, emotional stress and smoking, which can trigger attacks.<\/li>\n\n\n\n<li><strong>Heat Maintenance:<\/strong>&nbsp;Wearing warm clothing, particularly during cold months, is recommended to prevent episodes of excessive vasoconstriction.<\/li>\n\n\n\n<li><strong>Stopping Smoking:<\/strong>&nbsp;Smoking can worsen the symptoms of Raynaud&#8217;s syndrome by reducing blood flow.&nbsp;Quitting smoking is often encouraged.<\/li>\n\n\n\n<li><strong>Vasodilator Medications:<\/strong>&nbsp;Certain medications, such as calcium channel blockers and angiotensin-converting enzyme (ACE) inhibitors, may be prescribed to dilate blood vessels and improve circulation.<\/li>\n\n\n\n<li><strong>Medications to Control Stress:<\/strong>&nbsp;Medications to help manage emotional stress may be recommended in some cases.<\/li>\n\n\n\n<li><strong>Surgical Interventions:<\/strong>&nbsp;In severe cases resistant to conservative treatments, surgical interventions such as sympathectomy (section of the nerves responsible for vasoconstriction) may be considered.<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading has-white-color has-text-color has-background has-link-color wp-elements-065d282d1231fbb6c2eea860a79d2442\" style=\"background-color:#2a4a3b\"><span class=\"ez-toc-section\" id=\"Prevention\"><\/span><strong>Prevention<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Protection Against the Cold:<\/strong>&nbsp;People with Raynaud&#8217;s syndrome are often sensitive to the cold.&nbsp;It is recommended to wear warm clothing, including insulated gloves and socks, to maintain body heat.<\/li>\n\n\n\n<li><strong>Avoidance of Emotional Stress:<\/strong>&nbsp;Emotional stress can trigger Raynaud&#8217;s attacks.&nbsp;Managing stress through relaxation techniques, meditation, yoga, or other methods can help reduce emotional triggers.<\/li>\n\n\n\n<li><strong>Stopping Smoking:<\/strong>&nbsp;Smoking can worsen the symptoms of Raynaud&#8217;s syndrome by reducing blood flow.&nbsp;Quitting smoking is not only beneficial for general health, but can also improve blood circulation.<\/li>\n\n\n\n<li><strong>Avoid Excessive Vibration:<\/strong>&nbsp;In certain professions, prolonged exposure to vibrations, such as those generated by the use of power tools, can be a trigger.&nbsp;If possible, taking regular breaks can help reduce this exposure.<\/li>\n\n\n\n<li><strong>Maintaining a Comfortable Temperature:<\/strong>&nbsp;Ensuring you maintain a comfortable ambient temperature at home and at work can help prevent Raynaud&#8217;s attacks.&nbsp;Using space heaters if necessary can be helpful.<\/li>\n\n\n\n<li><strong>Moderate Physical Exercise:<\/strong>&nbsp;Moderate physical exercise can improve blood circulation.&nbsp;However, it is important to choose appropriate activities and consult a healthcare professional before starting an exercise program.<\/li>\n\n\n\n<li><strong>Balanced Diet:<\/strong>&nbsp;Adopting a balanced diet can help maintain good vascular health.&nbsp;It is recommended to favor a diet rich in fruits, vegetables, whole grains and to limit the consumption of foods rich in saturated fats.<\/li>\n\n\n\n<li><strong>Regular Medical Follow-up:<\/strong>&nbsp;Regular medical follow-up with a health professional, generally a rheumatologist, makes it possible to monitor the evolution of Raynaud&#8217;s syndrome and adjust the treatment plan if necessary.<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading has-white-color has-text-color has-background has-link-color wp-elements-d6ab0299a10e5dad715d342156aa2c5e\" style=\"background-color:#2a4a3b\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>In conclusion, Raynaud&#8217;s syndrome is a vascular condition characterized by excessive constriction of small arteries, usually triggered by cold or emotional stress.&nbsp;Although often mild, this syndrome can cause uncomfortable symptoms and, in some cases, serious complications.&nbsp;The pathophysiology of Raynaud syndrome involves an abnormal vascular response, leading to color and temperature changes in the affected areas.<\/p>\n\n\n\n<p>Diagnosis of Raynaud syndrome is based on a thorough evaluation of symptoms, medical history and clinical tests.&nbsp;Management of this condition aims to alleviate symptoms, prevent complications and improve the quality of life of affected individuals.&nbsp;Treatments may include lifestyle modifications, vasodilator medications, stress management, and in some cases, surgical procedures.<\/p>\n\n\n\n<p>Prevention of Raynaud&#8217;s syndrome focuses on reducing potential triggers such as cold and stress, as well as managing risk factors.&nbsp;Simple measures, such as wearing warm clothing, avoiding tobacco, and finding stress management methods, can help minimize seizures.<\/p>\n\n\n\n<p>Finally, it is essential to emphasize that each individual reacts differently to Raynaud&#8217;s syndrome, and an individualized approach to treatment and prevention is crucial.&nbsp;Close collaboration with health professionals, regular follow-ups and continued awareness-raising are fundamental to optimize the management of this condition and improve the quality of life of people affected by it.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-white-color has-text-color has-background has-link-color wp-elements-08bb71f1176734c9906ef40b6b52c98a\" style=\"background-color:#2a4a3b\"><span class=\"ez-toc-section\" id=\"References\"><\/span><strong>References<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Ventura I, Reid P, Jan R. Approach to Patients with Suspected Rheumatic Disease.&nbsp;Prim Care.&nbsp;2018 Jun;45(2):169-180.&nbsp;[&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29759118\">PubMed<\/a>&nbsp;]2.<\/li>\n\n\n\n<li>Pauling JD, Reilly E, Smith T, Frech TM.&nbsp;Evolving Symptom Characteristics of Raynaud&#8217;s Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity.&nbsp;Arthritis Care Res (Hoboken).&nbsp;2019 Aug;71(8):1119-1126.&nbsp;[&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30133174\">PubMed<\/a>&nbsp;]3.<\/li>\n\n\n\n<li>Fern\u00e1ndez-Codina A, Walker KM, Pope JE., Scleroderma Algorithm Group.&nbsp;Treatment Algorithms for Systemic Sclerosis According to Experts.&nbsp;Arthritis Rheumatol.&nbsp;2018 Nov;70(11):1820-1828.&nbsp;[&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29781586\">PubMed<\/a>&nbsp;]4.<\/li>\n\n\n\n<li>Wollina U, Koch A, Langner D, Hansel G, Heinig B, Lotti T, Tchernev G. Acrocyanosis \u2013 A Symptom with Many Facets.&nbsp;Open Access Maced J Med Sci.&nbsp;2018 Jan 25;6(1):208-212.&nbsp;[&nbsp;<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5816301\/\">PMC free article<\/a>&nbsp;] [&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29484025\">PubMed<\/a>&nbsp;]5.<\/li>\n\n\n\n<li>Ruaro B, Sulli A, Smith V, Pizzorni C, Paolino S, Alessandri E, Cutolo M. Microvascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques.&nbsp;Reumatism.&nbsp;2017 Dec 21;69(4):147-155.&nbsp;[&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29320840\">PubMed<\/a>&nbsp;]6.<\/li>\n\n\n\n<li>Belch J, Carlizza A, Carpentier PH, Constans J, Khan F, Wautrecht JC, Visona A, Heiss C, Brodeman M, P\u00e9csv\u00e1rady Z, Roztocil K, Colgan MP, Vasic D, Gotts\u00e4ter A, Amann-Vesti B, Chraim A, Poredo\u0161 P, Olinic DM, Madaric J, Nikol S, Herrick AL, Sprynger M, Klein-Weigel P, Hafner F, Staub D, Zeman Z. ESVM guidelines \u2013 the diagnosis and management of Raynaud&#8217;s phenomenon.&nbsp;Vasa.&nbsp;2017 Oct;46(6):413-423.&nbsp;[&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28895508\">PubMed<\/a>&nbsp;]7.<\/li>\n\n\n\n<li>Ingegnoli F, Ughi N, Dinsdale G, Orenti A, Boracchi P, Allanore Y, Foeldvari I, Sulli A, Cutolo M, Smith V, Herrick AL., EULAR Study Group on Microcirculation in Rheumatic Diseases.&nbsp;An international SURVEY on non-invaSive techniques to assess the microcirculation in patients with RayNaud&#8217;s phenomenon (SUNSHINE survey).&nbsp;Rheumatol Int.&nbsp;2017 Nov;37(11):1879-1890.&nbsp;[&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28894946\">PubMed<\/a>&nbsp;]8.<\/li>\n\n\n\n<li>Lee KA, Chung HW, Lee SH, Kim HR.&nbsp;The use of hand perfusion scintigraphy to assess Raynaud&#8217;s phenomenon associated with hand-arm vibration syndrome.&nbsp;Clin Exp Rheumatol.&nbsp;2017 Sep-Oct;35 Suppl 106(4):138-143.&nbsp;[&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28664836\">PubMed<\/a>&nbsp;]9.<\/li>\n\n\n\n<li>Vidal C, Ruano C, Bernardino V, Lavado Carreira P, Llad\u00f3 A, Santos MC, Gruner H, Panarra A, Riso N, Moraes-Fontes MF.&nbsp;Clinical Presentation and Long-Term Outcomes of Systemic Sclerosis Portuguese Patients from a Single Center Cohort: A EUSTAR Registration Initiative.&nbsp;Acta Med Port.&nbsp;2018 Jun 29;31(6):312-320.&nbsp;[&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30020876\">PubMed<\/a>&nbsp;]10.<\/li>\n\n\n\n<li>Ingegnoli F, Ughi N, Crotti C, Mosca M, Tani C. Outcomes, rates and predictors of transition of isolated Raynaud&#8217;s phenomenon: a systematic review and meta-analysis.&nbsp;Swiss Med Wkly.&nbsp;2017;147:w14506.&nbsp;[&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28975961\">PubMed<\/a>&nbsp;]11.<\/li>\n\n\n\n<li>Mirbod SM, Sugiura H. A non-invasive technique for the evaluation of peripheral circulatory functions in female subjects with Raynaud&#8217;s phenomenon.&nbsp;IndHealth.&nbsp;2017 Jun 08;55(3):275-284.&nbsp;[&nbsp;<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5462643\/\">PMC free article<\/a>&nbsp;] [&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28321017\">PubMed<\/a>&nbsp;]12.<\/li>\n\n\n\n<li>Daniels J, Pauling JD, Eccelston C. Behavior change interventions for the management of Raynaud&#8217;s phenomenon: a systematic review protocol.&nbsp;BMJ Open.&nbsp;2017 Aug 04;7(8):e017039.&nbsp;[&nbsp;<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5724227\/\">PMC free article<\/a>&nbsp;] [&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28780561\">PubMed<\/a>&nbsp;]13.<\/li>\n\n\n\n<li>Pain CE, Constantin T, Toplak N, Moll M, Iking-Konert C, Piotto DP, Aktay Ayaz N, Nemcova D, Hoeger PH, Cutolo M, Smith V, Foeldvari I., Pediatric Rheumatology European Society (PRES) Juvenile Scleroderma Working Group.&nbsp;Raynaud&#8217;s syndrome in children: systematic review and development of recommendations for assessment and monitoring.&nbsp;Clin Exp Rheumatol.&nbsp;2016 Sep-Oct;34 Suppl 100(5):200-206.&nbsp;[&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27494080\">PubMed<\/a>&nbsp;]14.<\/li>\n\n\n\n<li>Pope J, Harding S, Khimdas S, Bonner A, Canadian Scleroderma Research Group.&nbsp;Baron M. Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group.&nbsp;J Rheumatol.&nbsp;2012 Mar;39(3):524-31.&nbsp;[&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22247347\">PubMed<\/a>&nbsp;]15.<\/li>\n\n\n\n<li>Klein-Weigel P, Opitz C, Riemekasten G. Systemic sclerosis \u2013 a systematic overview: part 1 \u2013 Raynaud&#8217;s disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance.&nbsp;Vasa.&nbsp;2011 Jan;40(1):6-19.&nbsp;[&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21283969\">PubMed<\/a>&nbsp;]<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Introduction Raynaud&#8217;s disease is a vascular condition characterized by sudden constriction of the small arteries that supply blood to the extremities of the body, primarily the fingers and toes.&nbsp;This phenomenon causes a temporary decrease in blood flow, leading to paleness or cyanosis of the skin, followed by redness and sometimes swelling when blood flow is [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":38574,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":"","iawp_total_views":2,"footnotes":""},"categories":[239,233,232,511],"tags":[],"class_list":{"0":"post-40169","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-circulatory-system","8":"category-feet","9":"category-hand","10":"category-raynauds-disease"},"_links":{"self":[{"href":"https:\/\/osteomag.ca\/en\/wp-json\/wp\/v2\/posts\/40169","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/osteomag.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/osteomag.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/osteomag.ca\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/osteomag.ca\/en\/wp-json\/wp\/v2\/comments?post=40169"}],"version-history":[{"count":0,"href":"https:\/\/osteomag.ca\/en\/wp-json\/wp\/v2\/posts\/40169\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/osteomag.ca\/en\/wp-json\/wp\/v2\/media\/38574"}],"wp:attachment":[{"href":"https:\/\/osteomag.ca\/en\/wp-json\/wp\/v2\/media?parent=40169"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/osteomag.ca\/en\/wp-json\/wp\/v2\/categories?post=40169"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/osteomag.ca\/en\/wp-json\/wp\/v2\/tags?post=40169"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}